Quadrant Capital Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-88
| Closed | -$1.71K | – | 2779 |
|
|
2023
Q2 | $1.71K | Sell |
88
-1,724
| -95% | -$33.5K | ﹤0.01% | 2443 |
|
|
2023
Q1 | $51.4K | Buy |
1,812
+960
| +113% | +$27.2K | 0.01% | 1226 |
|
|
2022
Q4 | $24.9K | Buy |
852
+250
| +42% | +$7.31K | ﹤0.01% | 1549 |
|
|
2022
Q3 | $16K | Buy |
602
+544
| +938% | +$14.5K | ﹤0.01% | 1674 |
|
|
2022
Q2 | $3K | Sell |
58
-68
| -54% | -$3.52K | ﹤0.01% | 2164 |
|
|
2022
Q1 | $6K | Buy |
126
+78
| +163% | +$3.71K | ﹤0.01% | 1881 |
|
|
2021
Q4 | $2K | Buy |
48
+4
| +9% | +$167 | ﹤0.01% | 2202 |
|
|
2021
Q3 | $2K | Buy |
44
+26
| +144% | +$1.18K | ﹤0.01% | 2212 |
|
|
2021
Q2 | $1K | Sell |
18
-18
| -50% | -$1K | ﹤0.01% | 2351 |
|
|
2021
Q1 | $2K | Buy |
36
+16
| +80% | +$889 | ﹤0.01% | 2134 |
|
|
2020
Q4 | $1K | Buy |
20
+4
| +25% | +$200 | ﹤0.01% | 2226 |
|
|
2020
Q3 | $1K | Hold |
16
| – | – | ﹤0.01% | 2095 |
|
|
2020
Q2 | $1K | Hold |
16
| – | – | ﹤0.01% | 2169 |
|
|
2020
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 2066 |
|